Impact of race on selecting appropriate patients for active surveillance with seemingly low-risk prostate cancer

Urology

Volumn 85, Issue 2, 2015, Pages 436-441

  Pietzak, Eugene J ^a   Van Arsdalen, Keith ^a   Patel, Kinnari ^a   Malkowicz, S Bruce ^a   Wein, Alan J ^a   Guzzo, Thomas J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE SURVEILLANCE; ADULT; AFRICAN AMERICAN; ARTICLE; CANCER CENTER; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FAMILIAL CANCER; FAMILY HISTORY; GLEASON SCORE; HUMAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PARAMETERS; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TREND STUDY; CAUCASIAN; COMPARATIVE STUDY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; RISK ASSESSMENT; WATCHFUL WAITING;

AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; WATCHFUL WAITING;

EID: 84921519179     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.09.065     Document Type: Article

References (19)

1. M.J. Resnick, T. Koyama, and K.H. Fan Long-term functional outcomes after treatment for localized prostate cancer N Engl J Med 368 2013 436 445
2. D. Sundi, A.E. Ross, and E.B. Humphreys African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? J Clin Oncol 31 2013 2991 2997
3. Y.S. Ha, A. Salmasi, and M. Karellas Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance Urology 81 2013 831 835
4. V. Iremashvili, M.S. Soloway, and D.L. Rosenberg Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance J Urol 187 2012 1594 1599
5. B.D. Odom, M.C. Mir, and S. Hughes Active surveillance for low-risk prostate cancer in African American men: a multi-institutional experience Urology 83 2014 364 368
6. M.R. Abern, M.R. Bassett, and M. Tsivian Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center Prostate Cancer Prostatic Dis 16 2013 85 90
7. A. Adamy, D.S. Yee, and K. Matsushita Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer J Urol 185 2011 477 482
8. J.L. Mohler, A.J. Armstrong, and R.R. Bahnson Prostate cancer, version 3.2012: featured updates to the NCCN guidelines J Natl Compr Canc Netw 10 2012 1081 1087
9. J.J. Tosoian, B.J. Trock, and P. Landis Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2011 2185 2190
10. R.C. van den Bergh, S. Roemeling, and M.J. Roobol Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly Eur Urol 55 2009 1 8
11. M.S. Soloway, C.T. Soloway, and A. Eldefrawy Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment Eur Urol 58 2010 831 835
12. J.M. Whitson, S.P. Porten, and J.F. Hilton The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer J Urol 185 2011 1656 1660
13. T.J. Guzzo, M.A. Vira, and W. Neway Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy Urology 69 2007 1147 1151
14. I.J. Powell The precise role of ethnicity and family history on aggressive prostate cancer: a review analysis Arch Esp Urol 64 2011 711 719
15. I.J. Powell, and A. Bollig-Fischer Minireview: the molecular and genomic basis for prostate cancer health disparities Mol Endocrinol 27 2013 879 891
16. J. Li, E. Mercer, and X. Gou Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes Am J Cancer Res 3 2013 127 151
17. D. Sundi, O.N. Kryvenko, and H.B. Carter Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men J Urol 191 2014 60 67
18. D.W. Lin, L.F. Newcomb, and E.C. Brown Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study Clin Cancer Res 19 2013 2442 2450
19. G. Chornokur, K. Dalton, and M.E. Borysova Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer Prostate 71 2011 985 997